Clinical Trial Update: PEARL Schizophrenia Maintenance [Phase 3]

View source ↗

Summary

Phase 3 PEARL Schizophrenia Maintenance trial has completed and results have been posted. The study, sponsored by Sumitomo Pharma America, evaluated maintenance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2014-09-25